<<

Hartford Healthcare HLS Fund

Full Portfolio Holdings* as of August 31, 2021 % of Security Coupon Maturity Shares/Par Market Value Net Assets UnitedHealth Group, Inc. 0.000 42,565 17,718,533 8.079 , Inc. 0.000 262,679 12,101,622 5.518 Eli Lilly & Co. 0.000 45,644 11,789,389 5.376 Danaher Corp. 0.000 26,662 8,642,754 3.941 Bristol-Myers Squibb Co. 0.000 103,512 6,920,812 3.156 Boston Scientific Corp. 0.000 150,136 6,778,640 3.091 Edwards Lifesciences Corp. 0.000 53,692 6,291,629 2.869 Stryker Corp. 0.000 21,023 5,825,473 2.656 AstraZeneca plc 0.000 88,912 5,181,791 2.363 HCA Healthcare, Inc. 0.000 20,045 5,070,984 2.312 Fixed Income Clearing Corp. Repurchase 0.020 9/1/2021 4,855,482 4,855,482 2.214 Agreement dated 01/29/2021 at 0.020%, due on 02/01/2021 with a maturity value of $20,065,950; collateralized by U.S. Treasury Bond at 3.000%, maturing 05/15/2047, with a market value of $20,467,316 Zoetis, Inc. 0.000 23,348 4,776,067 2.178 Agilent Technologies, Inc. 0.000 26,287 4,612,580 2.103 Becton Dickinson and Co. 0.000 18,053 4,543,940 2.072 Humana, Inc. 0.000 10,536 4,271,505 1.948 Syneos Health, Inc. 0.000 38,050 3,530,279 1.610 Zai Lab Ltd. 0.000 23,713 3,422,972 1.561 Illumina, Inc. 0.000 7,413 3,388,927 1.545 Seagen, Inc. 0.000 19,127 3,205,685 1.462 Align Technology, Inc. 0.000 4,283 3,036,647 1.385 , Inc. 0.000 7,083 2,801,043 1.277 Baxter International, Inc. 0.000 33,236 2,533,248 1.155 Centene Corp. 0.000 39,466 2,485,569 1.133 Astellas Pharma, Inc. 0.000 137,700 2,320,233 1.058 Co., Ltd. 0.000 97,135 2,307,191 1.052 Alnylam Pharmaceuticals, Inc. 0.000 11,160 2,247,959 1.025 Laboratory Corp. of America Holdings 0.000 7,384 2,240,158 1.021 Eisai Co., Ltd. 0.000 24,909 2,054,238 0.937 Hologic, Inc. 0.000 24,276 1,921,445 0.876 Encompass Health Corp. 0.000 24,272 1,904,138 0.868 Amicus Therapeutics, Inc. 0.000 157,189 1,790,383 0.816 Molina Healthcare, Inc. 0.000 6,599 1,773,613 0.809 Goldman Sachs Financial Square Funds, 0.026 9/1/2021 1,762,701 1,762,701 0.804 Government Fund, Institutional Class Roche Holding AG 0.000 4,356 1,749,173 0.798 Exact Sciences Corp. 0.000 16,459 1,717,990 0.783 Insulet Corp. 0.000 5,460 1,626,043 0.741 Koninklijke Philips N.V. 0.000 34,426 1,586,458 0.723 Veracyte, Inc. 0.000 32,541 1,565,548 0.714 Merus N.V. 0.000 57,812 1,507,737 0.688 UCB S.A. 0.000 12,666 1,449,104 0.661 Genmab A/S 0.000 2,847 1,348,717 0.615 Page 1 of 3 HARTFORD FUNDS 08.31.21(unaudited) Hartford Healthcare HLS Fund

Full Portfolio Holdings* as of August 31, 2021 % of Security Coupon Maturity Shares/Par Market Value Net Assets Ono Pharmaceutical Co., Ltd. 0.000 55,376 1,329,601 0.606 Arena Pharmaceuticals, Inc. 0.000 24,308 1,286,379 0.587 Verve Therapeutics, Inc. 0.000 18,357 1,284,256 0.586 ALX Oncology Holdings, Inc. 0.000 17,770 1,243,900 0.567 Ascendis Pharma A/S 0.000 7,890 1,236,600 0.564 Bio-Techne Corp. 0.000 2,437 1,216,404 0.555 Celldex Therapeutics, Inc. 0.000 22,825 1,201,736 0.548 Hypera S.A. 0.000 174,000 1,196,948 0.546 Kymera Therapeutics, Inc. 0.000 19,176 1,191,597 0.543 Smith & Nephew plc 0.000 61,525 1,178,144 0.537 Tecan Group AG 0.000 1,913 1,167,160 0.532 Blueprint Medicines Corp. 0.000 12,478 1,163,823 0.531 InnoCare Pharma Ltd. 0.000 407,000 1,136,776 0.518 NanoString Technologies, Inc. 0.000 19,413 1,129,837 0.515 Connect Biopharma Holdings Ltd. 0.000 47,781 1,121,420 0.511 WuXi AppTec Co., Ltd. 0.000 56,154 1,119,882 0.511 Apellis Pharmaceuticals, Inc. 0.000 16,887 1,112,009 0.507 Mirati Therapeutics, Inc. 0.000 6,423 1,090,176 0.497 Ironwood Pharmaceuticals, Inc. 0.000 82,615 1,082,257 0.493 AG 0.000 11,563 1,069,472 0.488 Kodiak Sciences, Inc. 0.000 11,061 1,041,725 0.475 Integra LifeSciences Holdings Corp. 0.000 13,712 1,031,554 0.470 0.000 12,579 1,026,468 0.468 Owens & Minor, Inc. 0.000 27,083 1,009,654 0.460 NeoGenomics, Inc. 0.000 20,620 1,002,544 0.457 Nurix Therapeutics, Inc. 0.000 30,982 997,311 0.455 Elanco Animal Health, Inc. 0.000 28,745 959,508 0.438 Madrigal Pharmaceuticals, Inc. 0.000 11,454 947,819 0.432 Argenx SE 0.000 2,809 929,835 0.424 LHC Group, Inc. 0.000 4,970 928,197 0.423 Quidel Corp. 0.000 7,164 923,798 0.421 BioAtla, Inc. 0.000 22,030 905,213 0.413 Notre Dame Intermedica Participacoes S.A. 0.000 57,100 882,760 0.403 Everest Medicines Ltd. 0.000 142,500 880,754 0.402 ImmunoGen, Inc. 0.000 134,419 813,235 0.371 iRhythm Technologies, Inc. 0.000 15,921 761,024 0.347 Revance Therapeutics, Inc. 0.000 28,229 755,973 0.345 DiaSorin S.p.A. 0.000 3,286 749,696 0.342 DA32 Life Science Tech Acquisition Corp. 0.000 73,600 718,336 0.328 PhaseBio Pharmaceuticals, Inc. 0.000 212,367 688,069 0.314 89bio, Inc. 0.000 35,846 663,509 0.303 Hutchmed China Ltd. 0.000 45,594 647,923 0.295 Venus MedTech Hangzhou, Inc. 0.000 135,500 641,358 0.292 Nippon Shinyaku Co., Ltd. 0.000 7,900 641,235 0.292 Sage Therapeutics, Inc. 0.000 13,454 621,709 0.283

Page 2 of 3 HARTFORD FUNDS 08.31.21(unaudited) Hartford Healthcare HLS Fund

Full Portfolio Holdings* as of August 31, 2021 % of Security Coupon Maturity Shares/Par Market Value Net Assets Shandong Weigao Group Medical Polymer 0.000 368,000 605,519 0.276 Co., Ltd. Glaukos Corp. 0.000 10,057 599,699 0.273 AdaptHealth Corp. 0.000 24,401 586,600 0.267 Myovant Sciences Ltd. 0.000 23,809 579,511 0.264 Masimo Corp. 0.000 2,120 575,665 0.262 Haemonetics Corp. 0.000 8,983 563,683 0.257 Kyowa Kirin Co., Ltd. 0.000 16,600 543,165 0.248 Gracell , Inc. 0.000 48,106 501,746 0.229 Aveanna Healthcare Holdings, Inc. 0.000 50,598 477,645 0.218 Invitae Corp. 0.000 15,700 465,191 0.212 MedTech Acquisition Corp. 0.000 46,066 461,581 0.210 Oscar Health, Inc. 0.000 29,369 457,863 0.209 plc 0.000 12,100 422,347 0.193 Inari Medical, Inc. 0.000 5,144 421,088 0.192 CSPC Pharmaceutical Group Ltd. 0.000 298,000 378,043 0.172 Karuna Therapeutics, Inc. 0.000 2,050 243,745 0.111 agilon health, Inc. 0.000 6,696 234,360 0.107 Zealand Pharma A/S 0.000 7,155 225,239 0.103 Radius Health, Inc. 0.000 14,535 201,455 0.092 Alpha Teknova, Inc. 0.000 9,850 187,249 0.085 Fidelity Investments Money Market Funds, 0.010 9/1/2021 179,585 179,585 0.082 Government Portfolio, Institutional Class Abcam plc 0.000 8,085 171,626 0.078 Theravance Biopharma, Inc. 0.000 20,407 169,378 0.077 Orion Acquisition Corp. 0.000 14,177 141,345 0.064 Invesco Government & Agency Portfolio, 0.026 9/1/2021 128,646 128,646 0.059 Institutional Class Dyne Therapeutics, Inc. 0.000 6,770 114,616 0.052 Citibank NA 0.070 9/1/2021 108,996 108,996 0.050 OTHER ASSETS LESS LIABILITIES (1,828,138) (0.834) TOTAL NET ASSETS 219,303,431

* This unaudited information is being presented pursuant to the Fund’s Policy on Disclosure of Portfolio Holdings. A discussion of the Fund’s policy may be viewed in the Fund’s Statement of Additional Information on hartfordfunds.com. Please note that certain Fund holdings (including, but not limited to, foreign currencies, currency contracts, equity and debt futures, equity and debt options, equity swaps and short-term investments) may have been included under “Other Assets” and may not be listed separately. For a complete list of portfolio holdings, please contact Hartford Funds at 888-843-7824. Investors should carefully consider a fund’s investment objectives, risks, charges and expenses. This and other important information is contained in a fund’s full prospectus and summary prospectus, which can be obtained by visiting hartfordfunds.com. Please read it carefully before investing.

Mutual funds are distributed by Hartford Funds Distributors, LLC (HFD), Member FINRA. Advisory services are provided by Hartford Funds Management Company, LLC (HFMC). Certain funds are sub-advised by Wellington Management Company LLP. HFD and HFMC are not affiliated with any sub-adviser.

210570 2/21

Page 3 of 3 HARTFORD FUNDS 08.31.21(unaudited)